Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006644,
umls-concept:C0006675,
umls-concept:C0018549,
umls-concept:C0026882,
umls-concept:C0030685,
umls-concept:C0036667,
umls-concept:C0054493,
umls-concept:C0178719,
umls-concept:C0205349,
umls-concept:C0312418,
umls-concept:C0391871,
umls-concept:C0439799,
umls-concept:C0596235,
umls-concept:C0680255,
umls-concept:C0751951,
umls-concept:C1283071,
umls-concept:C1861762,
umls-concept:C1963578
|
pubmed:issue |
42
|
pubmed:dateCreated |
1997-11-17
|
pubmed:abstractText |
Malignant hyperthermia (MH) and central core disease (CCD) are autosomal dominant disorders of skeletal muscle in which a potentially fatal hypermetabolic crisis can be triggered by commonly used anesthetic agents. To date, 17 mutations in the human RYR1 gene encoding the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum (the ryanodine receptor) have been associated with MH and/or CCD. Although many of these mutations have been linked to MH and/or CCD, with high lod (log of the odds favoring linkage versus nonlinkage) scores, others have been found in single, small families. Independent biochemical evidence for a causal role for these mutations in MH is available for only two mutants. Mutations corresponding to the human MH mutations were made in a full-length rabbit RYR1 cDNA, and wild type and mutant cDNAs were transfected into HEK-293 cells. After about 48 h, intact cells were loaded with the fluorescent Ca2+ indicator, fura-2, and intracellular Ca2+ release, induced by caffeine or halothane, was measured by photometry. Ca2+ release in cells expressing MH or CCD mutant ryanodine receptors was invariably significantly more sensitive to low concentrations of caffeine and halothane than Ca2+ release in cells expressing wild type receptors or receptors mutated in other regions of the molecule. Linear regression analysis showed that there is a strong correlation (r = 0.95, p < 0.001) between caffeine sensitivity of different RYR1 mutants measured by the cellular Ca2+ photometry assay and by the clinical in vitro caffeine halothane contracture test (IVCT). The correlation was weaker, however, for halothane (r = 0.49, p > 0.05). Abnormal sensitivity in the Ca2+ photometry assay provides supporting evidence for a causal role in MH for each of 15 single amino acid mutations in the ryanodine receptor. The study demonstrates the usefulness of the cellular Ca2+ photometry assay in the assessment of the sensitivity to caffeine and halothane of specific ryanodine receptor mutants.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Caffeine,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Complementary,
http://linkedlifedata.com/resource/pubmed/chemical/Halothane,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ryanodine Receptor Calcium Release...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
272
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
26332-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9334205-Animals,
pubmed-meshheading:9334205-Caffeine,
pubmed-meshheading:9334205-Calcium,
pubmed-meshheading:9334205-Cell Line,
pubmed-meshheading:9334205-DNA, Complementary,
pubmed-meshheading:9334205-Halothane,
pubmed-meshheading:9334205-Humans,
pubmed-meshheading:9334205-Malignant Hyperthermia,
pubmed-meshheading:9334205-Mutagenesis, Site-Directed,
pubmed-meshheading:9334205-Myopathies, Nemaline,
pubmed-meshheading:9334205-Rabbits,
pubmed-meshheading:9334205-Recombinant Proteins,
pubmed-meshheading:9334205-Ryanodine Receptor Calcium Release Channel
|
pubmed:year |
1997
|
pubmed:articleTitle |
Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.
|
pubmed:affiliation |
Banting and Best Department of Medical Research, University of Toronto, Charles H. Best Institute, Toronto, Ontario M5G 1L6, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|